The current cost of heart failure to the National Health Service in the UK

Abstract

We have recently shown that heart failure admission rates continue to increase in the UK ᎏ particularly in older age groups. As hospital activity represents the major cost component of healthcare expenditure related to heart failure, this study Ž . evaluated the current cost of this syndrome to the National Health Service NHS in the UK. We applied contemporary estimates of healthcare activity associated with heart failure to the whole UK population on an age and sex-specific basis to calculate its cost to the NHS for the year 1995. Direct components of healthcare included in these estimates were hospital admissions associated with a principal diagnosis of heart failure, associated outpatient consultations, general practice consultations and prescribed drug therapy. We also calculated the cost of nursing-home care following a primary heart failure admission and the cost of hospitalisations associated with a secondary diagnosis of heart failure. Adjusting for probable increases in hospital activity and the progressive ageing of the UK population, we have also projected the cost of heart failure to the NHS for the year 2000. We estimated that there were 988 000 individuals requiring treatment for heart failure in the UK during 1995. The 'direct' cost of healthcare for these patients was estimated to be £716 million, or 1.83% of total NHS expenditure. Hospitalisations and drug prescriptions accounted for 69 and 18% of this expenditure, respectively. The additional costs associated with long-term nursing home care and secondary heart failure admissions accounted for a further Ž . £751 million 2.0% of total NHS expenditure . By the year 2000, we estimated that the combined total direct cost of heart failure would have risen to £905 million ᎏ equivalent to 1.91% of total NHS expenditure. Using well-validated sets of data, these findings re-confirm the importance of heart failure as a major public health problem in the UK. The annual direct cost of heart failure to the NHS in 2000 is likely to be of the order of 1.9% of total expenditure ᎏ the predominant cost component being hospitalisation. ᮊ

Cost-effectiveness analysis of ferric carboxymaltose in iron-deficient patients with chronic heart failure in Sweden

“…CHF patients are frequently hospitalized and CHF is the most common cause of hospitalization in patients aged over 65 years (19). Hospitalization is by far the greatest cost component of total healthcare expenditure for CHF, accounting for 47-69% of total expenditures, whereas medications stand for some 18% and the remainder for nursing homes, primary and ambulatory care visits (14,27). Apart from the economic burden, CHF is a major cause of reduced HRQoL (4).…”

Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment

“…Mortality from severe heart failure may be related, at least in part, to thrombotic events in the coronary and cerebral vasculature [23]. Several studies of platelet function have been performed in patients with heart failure (reviewed in ref.…”

Role of the fatty acid-binding protein 4 in heart failure and cardiovascular disease

“…Between the EU and the United States, there are more than 20 million people afflicted with this pathology (Mosterd & Hoes 2007, Mozaffarian et al 2015. It is estimated that HF is currently the leading cause of hospitalisation in people over the age of 65 years (Forman et al 2009), and approximately 108 billion dollars are spent each year on health costs associated with this pathology (Stewart et al 2002, Neumann et al 2009, Cook et al 2014. Despite advances in the treatment of HF and the amount of money invested to combating this pathology, the number of deaths as a consequence of HF is steadily increasing.…”